Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Name: Immuneering Corp - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Immuneering Corp - Ordinary Shares Class A
Rating: 1.52708325
Author: Trendlyne DVM scores

about

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

5.51 -0.10 (-1.78%)

45.34% Fall from 52W High

125.4K

XNAS Volume

XNAS 21 Oct, 2025 10:12 AM (EDT)

Not Eligible

Expensive Valuation

2.3 / 100

Technically Neutral

58.8 / 100

No estimates available

Immuneering Corp Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

45.34% Fall from 52W High

SWOT Analysis

Immuneering Corp Ordinary Live Price Chart